Tamoxifen induced-thrombocytopenia: it does occur.
Tamoxifen has been in the center of management of hormone-sensitive breast cancer. Furthermore, it represents the best example of chemo-prevention: It reduces the incidence of invasive breast cancer. However, it has some side effects, several of them are severe. Oncologists, hematologists, internal medicine specialists and gynecologists must know this agent in detail. Authors report a very rare side effect, thrombocytopenia, and discuss it briefly.
Nasiroğlu
Narin
N
Dahiliye Klinigi, Ankara Numune Hastanesi, Ankara, Turkey.
Pamukçuoğlu
Merve
M
Abali
Hüseyin
H
Oksüzoğlu
Berna
B
Uner
Ayşegül
A
Zengin
Nurullah
N
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D044584:Carcinoma, Ductal / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D008875:Middle Aged; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000175:diagnosis*; D028761:Withholding Treatment
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen